Fig. 4From: Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning studyCL0.0 to CL5.0 for VMAT 10MV FFF and 6MV FF in the central tumor location and either 14Â cm3 or 268Â cm3 PTV volumeBack to article page